|
000
| 01154nam##2200265za#4500 |
|---|
| 001 | 9.620226 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20200401020321 |
|---|
| 007 | ta |
|---|
| 008 | 150406|2011||||xxc||||| f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-19401-1 |
|---|
| 022 | |a0821-8110 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aFA1-2011/2-4E |
|---|
| 110 | 1 |aCanada. |bOffice of the Auditor General. |
|---|
| 245 | 10|aReport of the Auditor General of Canada to the House of Commons. Chapter 4, : |bRegulating pharmaceutical drugs - Health Canada |
|---|
| 260 | |aOttawa - Ontario : |bOffice of the Auditor General of Canada |
|---|
| 300 | |aiii, 38p. : |btables ; |c28 cm. |
|---|
| 490 | 1 |aReport of the Auditor General of Canada to the House of Commons|x0821-8110|vFall 2011 |
|---|
| 563 | |aSoftcover |
|---|
| 590 | |a12-07|b2012-02-17 |
|---|
| 775 | 08|tRapport du vérificateur général du Canada à la Chambre des communes. Chapitre 4, : |w(CaOODSP)9.628879 |
|---|
| 776 | 0#|tReport of the Auditor General of Canada to the House of Commons. Chapter 4, : |w(CaOODSP)9.571770 |
|---|
| 830 | #0|aReport of the Auditor General of Canada to the House of Commons,|x0821-8110|vFall 2011|w(CaOODSP)9.515730 |
|---|